Avid Bioservices, Inc. (CDMO): Price and Financial Metrics

Avid Bioservices, Inc. (CDMO): $6.74

0.16 (-2.32%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

CDMO Price/Volume Stats

Current price $6.74 52-week high $21.05
Prev. close $6.90 52-week low $4.07
Day low $6.61 Volume 785,600
Day high $6.96 Avg. volume 1,305,855
50-day MA $7.00 Dividend yield N/A
200-day MA $8.45 Market Cap 426.23M

CDMO Stock Price Chart Interactive Chart >


Avid Bioservices, Inc. (CDMO) Company Bio


Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate includes bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company was founded in 1981 and is based in Tustin, California.


CDMO Latest News Stream


Event/Time News Detail
Loading, please wait...

CDMO Latest Social Stream


Loading social stream, please wait...

View Full CDMO Social Stream

Latest CDMO News From Around the Web

Below are the latest news stories about AVID BIOSERVICES INC that investors may wish to consider to help them evaluate CDMO as an investment opportunity.

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

Investors often keep a close eye on insider transactions as they can provide valuable insights into a company's prospects.

Yahoo | December 19, 2023

Avid Bioservices, Inc. (CDMO) Q2 2024 Earnings Call Transcript

Avid Bioservices, Inc. (CDMO)

Q2 2024 Earnings Conference Call

December 7, 2023, 4:30 PM ET

Company Participants

Tim Brons - Investors Relations Group

Nick Green - President and CEO

Dan Hart - Chief Financial Officer

Matt Kwietniak - Chief Commercial Officer

Conference Call Participants

Jacob Johnson - Stephens

Matt Hewitt - Craig-Hallum

Paul Knight - KeyBanc

Max Smock - William Blair

Thomas Kelliher - RBC Capital Markets

Presentation

Operator

Good day, ladies and gentlemen. And welcome to the Avid Bioservices Second Quarter Fiscal 2024 Financial Results Conference Call. At this time, all participants are in a listen-only ...

SA Transcripts on Seeking Alpha | December 8, 2023

JOBY Stock: Joby Aviation Announces Partnerships to Boost eVTOL Infrastructure

Joby Aviation stock is climbing higher on Friday as investors in the company react to a new partnership to bring eVTOLs to Japan.

William White on InvestorPlace | December 8, 2023

Morgan Stanley Is Pounding the Table on First Solar (FSLR) Stock

First Solar stock is climbing higher on Friday after shares of FSLR were given an upgrade and increased price target from Morgan Stanley.

William White on InvestorPlace | December 8, 2023

Why Is Avid Bioservices (CDMO) Stock Down 18% Today?

Avid Bioservices stock is falling hard on Friday as investors in CDMO react to a lackluster earnings report and a guidance cut.

William White on InvestorPlace | December 8, 2023

Read More 'CDMO' Stories Here

CDMO Price Returns

1-mo 7.15%
3-mo 9.42%
6-mo -9.89%
1-year -65.72%
3-year -64.82%
5-year 56.38%
YTD 3.69%
2023 -52.80%
2022 -52.81%
2021 152.86%
2020 50.46%
2019 87.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!